Standard Care (which may include intravenous Alteplase)

DRUG2 trials

Sponsors

University of Melbourne

Conditions

Basilar Artery OcclusionIschemic Stroke

Phase 2

Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke

RecruitingNCT05105633

University of MelbourneBasilar Artery Occlusion

Start: 2021-11-29End: 2029-05-01Target: 688Updated: 2026-05-06

Phase 3

Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion

TerminatedNCT04454788

University of MelbourneIschemic Stroke

Start: 2020-08-01End: 2025-01-06Updated: 2025-01-15

Related Papers

Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled Trial

Stroke2025-09-101 citations

Extending the time window for tenecteplase by effective reperfusion of penumbral tissue in patients with large vessel occlusion: Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 trial

International Journal of Stroke2024-12-108 citations

Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial.

2024-11-0513 citations

Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial

Stroke and Vascular Neurology2023-05-2914 citations